D-1118-2017 Class III Terminated
FDA drug recall D-1118-2017 was initiated by PD-Rx Pharmaceuticals, Inc. on Aug 11, 2017 and is designated Class III. Reason for recall: Failed Impurities/Degradation Specifications:Out of specification results for individual unknown impurities at 30th month Room Temperature Retained Sample stabilities test . The recall status is terminated (terminated Jan 29, 2020). Affected quantity: 3440 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Aug 30, 2017
- Initiation Date
- Aug 11, 2017
- Termination Date
- Jan 29, 2020
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 3440 bottles
Product description
Phentermine Capsules, 15 mg, a) 7-count bottle (NDC 55289-791-07), b) 14-count bottle ( NDC 55289-791-14), c) 21-count bottle (NDC 55289-791-21), d) 30-count bottle (NDC 55289-791-30), e) 60-count bottle (NDC 55289-791-60), Packaged by PD-Rx Pharmaceuticals, Incorporated, Oklahoma City, OK. 73127 Mfg: KVK-Tech, Inc. Newtown, PA 18940
Reason for recall
Failed Impurities/Degradation Specifications:Out of specification results for individual unknown impurities at 30th month Room Temperature Retained Sample stabilities test .
Distribution pattern
Nationwide.
Code information
Lots: a) H15E22, Exp. 8/31/17; J15E02, Exp. 10/31/17. b) J15A53, Exp. 10/31/17; D16C78, Exp.12/31/17; c)J15D54, Exp. 10/31/17; d)H15B60, Exp. 8/31/17; e) J15A49, Exp. 10/31/17; C16A14, Exp. 12/31/17.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1118-2017
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026